Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Psyched Wellness shares key milestone in Maximum Tolerated Dosage study of Amanita Muscaria extract

Psyched Wellness shares key milestone in Maximum Tolerated Dosage study of Amanita Muscaria extract

Psyched Wellness Ltd (CSE:PSYC) (OTCQB:PSYCF) CEO Jeffrey Stevens tells Proactive the life sciences company revealed the results from its Maximum Tolerated Dosage (MTD) study of AME-1 conducted by KGK Science.

Stevens says this key milestones gives the group the MTD safe for consumption. Now, the group will move into a 14-day and then a 90-day oral toxicity study.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK